These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 31362825)

  • 1. A phase II, multicenter, open-label trial of OTL38 injection for the intra-operative imaging of folate receptor-alpha positive ovarian cancer.
    Randall LM; Wenham RM; Low PS; Dowdy SC; Tanyi JL
    Gynecol Oncol; 2019 Oct; 155(1):63-68. PubMed ID: 31362825
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Novel Tumor-Specific Agent for Intraoperative Near-Infrared Fluorescence Imaging: A Translational Study in Healthy Volunteers and Patients with Ovarian Cancer.
    Hoogstins CE; Tummers QR; Gaarenstroom KN; de Kroon CD; Trimbos JB; Bosse T; Smit VT; Vuyk J; van de Velde CJ; Cohen AF; Low PS; Burggraaf J; Vahrmeijer AL
    Clin Cancer Res; 2016 Jun; 22(12):2929-38. PubMed ID: 27306792
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Phase III Study of Pafolacianine Injection (OTL38) for Intraoperative Imaging of Folate Receptor-Positive Ovarian Cancer (Study 006).
    Tanyi JL; Randall LM; Chambers SK; Butler KA; Winer IS; Langstraat CL; Han ES; Vahrmeijer AL; Chon HS; Morgan MA; Powell MA; Tseng JH; Lopez AS; Wenham RM
    J Clin Oncol; 2023 Jan; 41(2):276-284. PubMed ID: 36070540
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intraoperative near-infrared imaging with receptor-specific versus passive delivery of fluorescent agents in pituitary adenomas.
    Cho SS; Jeon J; Buch L; Nag S; Nasrallah M; Low PS; Grady MS; Singhal S; Lee JYK
    J Neurosurg; 2019 Dec; 131(6):1974-1984. PubMed ID: 30554181
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The feasibility of folate receptor alpha- and HER2-targeted intraoperative fluorescence-guided cytoreductive surgery in women with epithelial ovarian cancer: A systematic review.
    de Jong JM; Hoogendam JP; Braat AJAT; Zweemer RP; Gerestein CG
    Gynecol Oncol; 2021 Aug; 162(2):517-525. PubMed ID: 34053747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Imaging before cytoreductive surgery in advanced ovarian cancer patients.
    Rizzo S; Del Grande M; Manganaro L; Papadia A; Del Grande F
    Int J Gynecol Cancer; 2020 Jan; 30(1):133-138. PubMed ID: 31754068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Updates on fluorescent probes and open-field imaging methods for fluorescence-guided cytoreductive surgery for epithelial ovarian cancer: A review.
    Sun C; Huang Y; Jiang C; Li Z
    BJOG; 2022 Nov; 129 Suppl 2(Suppl 2):50-59. PubMed ID: 36485071
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intraoperative imaging of folate receptor alpha positive ovarian and breast cancer using the tumor specific agent EC17.
    Tummers QR; Hoogstins CE; Gaarenstroom KN; de Kroon CD; van Poelgeest MI; Vuyk J; Bosse T; Smit VT; van de Velde CJ; Cohen AF; Low PS; Burggraaf J; Vahrmeijer AL
    Oncotarget; 2016 May; 7(22):32144-55. PubMed ID: 27014973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic value of integrated ¹⁸F-fluoro-2-deoxyglucose positron emission tomography/computed tomography in recurrent epithelial ovarian cancer: accuracy of patient selection for secondary cytoreduction in 134 patients.
    Lee YJ; Kim YM; Jung PS; Lee JJ; Kim JK; Kim YT; Nam JH
    J Gynecol Oncol; 2018 May; 29(3):e36. PubMed ID: 29400023
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intraoperative Molecular Imaging Utilizing a Folate Receptor-Targeted Near-Infrared Probe Can Identify Macroscopic Gastric Adenocarcinomas.
    Newton AD; Predina JD; Frenzel-Sulyok LG; Low PS; Singhal S; Roses RE
    Mol Imaging Biol; 2021 Feb; 23(1):11-17. PubMed ID: 33033941
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ARIA II: a randomized controlled trial of near-infrared Angiography during RectosIgmoid resection and Anastomosis in women with ovarian cancer.
    Leitao MM; Iasonos A; Tomberlin M; Moukarzel LA; Price H; Bennetti G; Ramesh B; Chi DS; Long Roche K; Sonoda Y; Al-Niami A; Mueller JJ; Gardner GJ; Broach V; Jewell EL; Kim S; Feinberg J; Abu-Rustum NR; Zivanovic O
    Int J Gynecol Cancer; 2024 Jul; 34(7):1098-1101. PubMed ID: 38514101
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Value of Intraoperative Near-Infrared Fluorescence Imaging Based on Enhanced Permeability and Retention of Indocyanine Green: Feasibility and False-Positives in Ovarian Cancer.
    Tummers QR; Hoogstins CE; Peters AA; de Kroon CD; Trimbos JB; van de Velde CJ; Frangioni JV; Vahrmeijer AL; Gaarenstroom KN
    PLoS One; 2015; 10(6):e0129766. PubMed ID: 26110901
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum folate receptor alpha as a biomarker for ovarian cancer: Implications for diagnosis, prognosis and predicting its local tumor expression.
    Kurosaki A; Hasegawa K; Kato T; Abe K; Hanaoka T; Miyara A; O'Shannessy DJ; Somers EB; Yasuda M; Sekino T; Fujiwara K
    Int J Cancer; 2016 Apr; 138(8):1994-2002. PubMed ID: 26595060
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CT prediction of surgical outcome in patients with advanced epithelial ovarian carcinoma undergoing neoadjuvant chemotherapy.
    Bregar A; Mojtahed A; Kilcoyne A; Kurra V; Melamed A; Growdon W; Alejandro Rauh-Hain J; Del Carmen M; Lee SI
    Gynecol Oncol; 2019 Mar; 152(3):568-573. PubMed ID: 30642626
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of a Short Versus Long Stokes Shift Near-Infrared Dye During Intraoperative Molecular Imaging.
    Corbett CJ; Frenzel Sulyok LG; Predina JD; Newton AD; Bryski MG; Xia L; Stadanlick J; Shin MH; Mahalingam SM; Low PS; Singhal S
    Mol Imaging Biol; 2020 Feb; 22(1):144-155. PubMed ID: 31820349
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A pre-operative predictive score to evaluate the feasibility of complete cytoreductive surgery in patients with epithelial ovarian cancer.
    Chesnais M; Lecuru F; Mimouni M; Ngo C; Fauconnier A; Huchon C
    PLoS One; 2017; 12(11):e0187245. PubMed ID: 29117194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of OTL38-Generated Tumor-to-Background Ratio in Intraoperative Molecular Imaging-Guided Lung Cancer Resections.
    Azari F; Kennedy G; Bernstein E; Delikatny J; Lee JYK; Kucharczuk J; Low PS; Singhal S
    Mol Imaging Biol; 2023 Feb; 25(1):85-96. PubMed ID: 34101106
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A multicenter, open-label, expanded phase 2 study to evaluate the safety and efficacy of etirinotecan pegol, a polymer conjugate of irinotecan, in women with recurrent platinum-resistant or refractory ovarian cancer.
    Rustin G; Vergote I; Micha JP; Duska LR; Reed N; Bendell J; Spitz D; Dark G; Hoch U; Tagliaferri M; Hannah AL; Garcia AA
    Gynecol Oncol; 2017 Nov; 147(2):276-282. PubMed ID: 28935273
    [TBL] [Abstract][Full Text] [Related]  

  • 19. When should Surgery be used for Recurrent Ovarian Carcinoma?
    Bommert M; Harter P; Heitz F; du Bois A
    Clin Oncol (R Coll Radiol); 2018 Aug; 30(8):493-497. PubMed ID: 29743148
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Near-infrared Fluorescence-guided Sentinel Node Mapping of the Ovary With Indocyanine Green in a Minimally Invasive Setting: A Feasible Study.
    Buda A; Passoni P; Corrado G; Bussi B; Cutillo G; Magni S; Vizza E
    J Minim Invasive Gynecol; 2017 Jan; 24(1):165-170. PubMed ID: 27670732
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.